News
15m
Asianet Newsable on MSNNovo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff PressureThe results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance.
Novo Nordisk A/S’s sales showed the weakest growth in four years as the Danish drugmaker loses ground to Eli Lilly & Co. in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results